Combination therapy in the treatment of experimental invasive fungal infection by Sarocladium (Acremonium) kiliense.

Int J Antimicrob Agents

Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Reus, Spain. Electronic address:

Published: August 2014

Since human infections by Sarocladium (Acremonium) kiliense are usually refractory to antifungal therapy, combinations of drugs are an option that needs exploring. The antifungal activities of anidulafungin plus posaconazole or voriconazole and of amphotericin B plus voriconazole were evaluated and their efficacy was tested in a murine model of disseminated infection by three S. kiliense strains. The results showed that although efficacy was strain-dependent, these combinations work better, in general, than monotherapies. The best results were obtained with the combination of anidulafungin plus posaconazole, although the in vitro assay showed indifference or an antagonistic effect.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijantimicag.2014.03.010DOI Listing

Publication Analysis

Top Keywords

sarocladium acremonium
8
acremonium kiliense
8
anidulafungin posaconazole
8
combination therapy
4
therapy treatment
4
treatment experimental
4
experimental invasive
4
invasive fungal
4
fungal infection
4
infection sarocladium
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!